OOIR: Observatory of International Research

Papers

(The median citation count of Beneficial Microbes is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Evaluation of the effectiveness of personalised therapy for the patients with irritable bowel syndrome	75
Impact of Lactiplantibacillus plantarum Inducia on metabolic and antioxidative response in cholesterol and BMI variable indices: randomised, double-blind, placebo-controlled trials	55
Synergistic effects of Lacticaseibacillus rhamnosus GG, glutamine, and curcumin on chronic unpredictable mild stress-induced depression in a mouse model	43
Limosilactobacillus reuteri ATCC 6475 metabolites upregulate the serotonin transporter in the intestinal epithelium	29
Effects of Bacillus pumilus on growth performance, serum indexes and muscle development-related gene expression of weanling Jintang black goat	24
A blend of 3 mushrooms dose-dependently increases butyrate production by the gut microbiota	24
IL-1β knockout increases the intestinal abundancy of Akkermansia muciniphila	20
Functional insights on probiotics activity in the gut from metagenomic data	19
Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy	19
Covariates of vaginal microbiota and pro-inflammatory cytokine levels in women of reproductive age	17
Probiotic-educated Tregs are more potent than naïve Tregs for immune tolerance in stressed new-born mice	16
Rotavirus immunisation status affects the efficacy of Lacticaseibacillus rhamnosus GG for the treatment of children with acute diarrhoea: a meta-analysis	16
Quantitative assessment of urinary equol levels, equol-producing bacteria, and the faecal microbiota in healthy Japanese individuals	15
Probiotics, prebiotics and postbiotics for better sleep quality: a narrative review	15
Short-chain fatty acids inhibit the activation of T lymphocytes and myeloid cells and induce innate immune tolerance	15
Foreword – Into the third year with COVID-19. Will gut microbiota be shown to play a role?	15
Effectiveness of two probiotics in preventing necrotising enterocolitis in a cohort of very-low-birth-weight premature new-borns	14
Heat-killed Lactobacillus helveticus improves mood states: a randomised, double-blind, placebo-controlled study	13
Probiotic adjuvant treatment in combination with scaling and root planing in chronic periodontitis: a systematic review and meta-analysis	13
Bacillus clausii UBBC-07 in the symptom management of upper respiratory tract infections in children: a double blind, placebo-controlled randomised study	13
Are fructophilic lactic acid bacteria (FLAB) beneficial to humans?	13
Effects of food matrix on the prebiotic efficacy of inulin-type fructans: a randomised trial	12
Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial	12
Novel ex vivo screening assay to preselect farm specific pre- and probiotics in pigs	12
Supplementation with heat-inactivated Lacticaseibacillus paracasei K47 ameliorates allergic asthma in mice by regulating the Th1/Th2 balance	11

Use of Limosilactobacillus reuteri DSM 17938 in paediatric gastrointestinal disorders: an updated review	10
Enterococcus faecium supplementation prevents enteritis caused by Escherichia coli in goats	10
The effects of physical activity on the modulation of gut microbiota composition: a systematic review	10
Lactobacillus crispatus DSM25988 as novel bioactive agent to co-aggregate Streptococcus pyogenes and to exclude it by binding to human cells	9
Lactation time influences the composition of Bifidobacterium and Lactobacillus at species level in human breast milk	9
Epigenetic regulation by metabolites from the gut microbiome	9
Agave fructans enhance the effects of fermented milk products on obesity biomarkers: a randomised trial	8
A probiotic amylase blend reduces gastrointestinal symptoms in a randomised clinical study	8
Innovations for microbiome targeting interventions – a patent landscape analysis indicating overall patenting activity decline and promising target disease areas	7
Fermented rape pollen powder can alleviate benign prostatic hyperplasia in rats by reducing hormone content and changing gut microbiota	7
Lacticaseibacillus rhamnosus and breastmilk are associated with a decreased risk of atopic dermatitis in very low birth weight premature infants	7
Post-immunobiotics increase resistance to primary respiratory syncytial virus infection and secondary pneumococcal pneumonia	7
Inadequate safety reporting in the publications of randomised clinical trials in irritable bowel syndrome: drug versus probiotic interventions	7
Efficacy of Bifidobacterium animalis subsp. lactis, BB-12® on infant colic – a randomised, double-blinded, placebo-controlled study	7
Effects of oral probiotic and lactoferrin interventions on iron-zinc homeostasis, oxidant/antioxidant equilibrium and diarrhoea incidence of neonatal piglets	6
Ingestion of Lactobacillus helveticus WHH1889 improves depressive and anxiety symptoms induced by chronic unpredictable mild stress in mice	6
Safety assessment and characterisation of Ligilactobacillus salivarius PS21603 as potential feed additive for swine	6
Evaluation of Bacillus clausii CSI08, Bacillus megaterium MIT411 and a Bacillus cocktail on gastrointestinal health: a randomised, double-blind, placebo-controlled pilot study	6
Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial	6
The gastrointestinal status of healthy adults: a post hoc assessment of the impact of three distinct probiotics	6